HOW TO PREPARE DOCUMENTATION IN INDUSTRY

                              DOCUMENTATION

INTRODUCTION :-

Documentation is covered by the Drugs Cosmetic Act 1940/Rules 1945 and is explained in schedule U of the said act.

Any anomoly in the documentation, if not explained properly by the staff, is deemed to be violation and the company is liable for penal action. Hence documentation must be taken as an individual responsibility and must be given the importance, it deserves.

Documentation is relevant in every phase of production facility, be it stores department to receive and dispense the material or Production department to produce the formulation or Quality Control department to carry out raw material/in process/finished product testing or Quality Assurance department to release the final goods to the customer.

Proper documentation is a primary requirement of CGMP (Current Good Manufacturing Practices) and it is indeed imperative that each member of the staff must be careful about documents under his/her control. The emphasis must be on zero defect, so that the final document kept as a record, will be defect free.

PARTICULARS TO BE SHOWN IN MANUFACTURING RECORDS FOR SUBSTANCES OTHER THAN PARENTERAL PREPARATION IN GENERAL

1.      Serial Number.

2.      Name of the Product.

3.      Reference of Master Formula Records.

4.      Lot /Batch Size.

5.      Lot / Batch Number.

6.      Date of commencement of manufacture and date of completion of manufacture and the assigned date of expiry.

7.       Name of all ingredients, specifications quantities required for the lot/Batch size and quantities actually used. All weighings and measurements shall be carried out by   a responsible person and initialed by him and shall be counter checked and signed by the competent technical staff under whose personal supervision the ingredients are used for manufacture.

8.      Control Numbers of raw materials used in the formulation.

9.      Date. time and duration of mixing.

10.    Detail of environmental controls like room temperature, relative humidity.

11.    Date of granulation, wherever applicable.

12.    Theoretical weight and actual weight of granules/powder blend.


13.    Records of in-processes controls (Periodically whenever necessary).
(a)          Uniformity of mixing.
(b)          Moisture content of granules/powder in case of Tablet/Capsules.
(c)           pH of solution in case of liquid.
(d)          Weight variation.
(e)          Disintegration time.
(I)            Hardness.
(g)          Friability test
(h)          Leak test in case of strip packing.
(i)            Filled volume of liquids.
j)             Quantity of tablets/capsules in the final container.
(k)           Content of ointment in the filled containers.

14.    Date of compression in case of Tablets / date of filling in case of capsules.

15.    Date of sealing/coating/polishing in case of capsules/tablets wherever applicable.

16.    Reference to analytical Report number stating the result of test and analysis.

17.    Separate records of the disposal of the rejected batches and of batches withdrawn from the market

18.    The theoretical yield and actual productions yield and packing particulars indicating the size and quantity of finished packings.

19.    Specimen of label / strip, carton with batch coding information like Batch Number, date of manufacture. date of expiry, retail price as applicable. stamped thereon and inserts used in the finished packings.

20.    Signature with date of competent technical staff responsible for the manufacture.

21.    Counter-signature of the head of the testing units or other approved person-in- charge of testing for having verified the batch records and for having released the batch for sale and distribution. the quantity released and date of release.

22.    Date of release of finished packings and quantity released for sale and distribution

23.    Quantity transferred to warehouse.

24.     For Hypodermic tablets and ophthalmic preparations which are required to be manufactured under  aseptic conditions, records shall be maintained indicating the precautions taken during the process of manufacture to ensure that aseptic conditions are maintained.

                                                 RECORDS OF RAW MATERIALS

Records in respect of each raw material shall be maintained indicating the date of receipt, invoice number. name and address of manufacturer/supplier, batch number, quantity received, pack size. date of manufacture date of expiry, if any, date of analysis and release/rejection by quality control, analytical report number. with special remarks. if any quantity issued, date of issue and the particulars of the name and batch numbers of products for the Manufacture of which issued and the proper disposal of the stocks.

                         PARTICULARS TO BE RECORDED IN THE ANALYTICAL RECORDS 

                                                     TABLETS AND CAPSULES.


1.      Analytical report number.

2.      Name of the sample.

3.      Date of receipt of sample.

4.      Batch/Lot number.

5.      Protocols of tests applied.
(a) Description.
(b) Identification.
(c) Uniformity of weight.
(d) Uniformity of diameter (if applicable).
(e) Disintegration test (time in minutes).
(I)  Any other tests.
(g) Results of Assay.

Note : Records regarding various tests applied (including readings and calculations) should be maintained and reference to these records should be entered in Col. 5 above whenever necessary.

6.      Signature of the Analyst.

7.      Opinion and signature of the approved Analyst.

                                                    FOR OTHER DRUGS 


1.      Analytical report number.

2.      Name of the sample.

3.      Batch/Lot number.

4.      Date of receipt of sample.

5.      Protocol of tests applied.
(a) Description.
(b) Identification.
(c) Any other tests
 (d) Results of Assay.

Note : Particulars regarding various test applied (including readings and calculations) shall be maintained and necessary reference to these records shall be entered in Column 5 above, wherever necessary.

6.      Signature of the Analyst.

7       Opinion and signature of the approved Analyst.

                                                                          

                                                                 RAW MATERIAL


1.      Serial number.

2.      Name of the materials.

3.      Name of the manufacturer/supplier.

4.      Quantity received.

5.      Invoice / Challan number and date.

6.      Protocols of tests applied.


                                          CONTAINER, PACKING MATERIAL


1.      Serial number.

2.      Name of the item.

3.      Name of the manufacturer/supplier.

4.      Quantity received.

5.      Invoice / Challan number and date.

6.      Results of tests applied.

Note : Particulars regarding various test applied shall be maintained and necessary reference to these records shall be entered in Column 6 above, wherever necessary.

7.      Remarks.

8.      Signature of the examiner.


                                              GENERAL ANOMOLIES



Some of the general anomolies observed in the BMR/BPR by Q.A., have been included in the following list

a)   Overwriting and excessive cancellations of entries.

b)   Signature of Production officer, competent person missing from the document.

c)   Entries missed on the document, although duly signed by Production officer.

d)   Wrong entries of container numbers.

e)   Wrong subtraction of Gross and Tare weights.

f)    Date column not filled.

g)   Sifter number not ticked. 

h)   Cleanliness record not completely filled, although document is duly signed by the production officer.

i)    Remark column not filled. If there is no relevant remark, the relevant column can have 'Nil' or ' -' as an entry.

j)     Some of the operations not bearing the initials of the operators involved in the operation; although signature of Production officer is available e.g. mixing operation in Norflox tablets.

k)   A series of humidity observations having only one signature at the top. All the observations must be individually signed.

l)    Bulk density, Friability and Sieve analysis figures are available; but the raw data is not available.
m) Average weight of the tablet after coating is calculated, but the methodology of calculation was not shown on the BMR.

n)   The word 'Production officer', was missing after conclusion of certain important steps like inspection and hence the relevant page was not signed by the "Production officer".

o)   Temperature not recorded during drying operation of one of the lots.

p)   BMR No./A.R.No. not mentioned.

q)   Soaking time does not match.

r)    Compressed air "Dew point" not recorded.

s)   ‘Checked by' not signed.

t)    Batch summary sheet not filled.

u)   The timings in the case of rinsing of pressure vessel in Aerosol manufacturing is recorded less than the timing required as per SOP.

v)   Reconciliation of cans does not tally.

w) The total weight of foil does not tally.

x)   Relevant S.O.P numbers were not ticked.

y)   In the rejected analysis sheet of BPR, the total is wrong or the total is available, without individual entries. Percentage of rejects calculated wrongly.

                                             

                                


No comments:

Post a Comment

How to Prepared and Standardize of 0.1 N Potassium Permanganate Volumetric solution.

How to Prepared and Standardize of 0.1 N Potassium Permanganate Volumetric solution.                                                  ...